HAW PAR ADR

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2026, HAW PAR ADR has already paid €1.10 in dividends. The last payout was in October.

Financials

In the last quarter, HAW PAR ADR had revenue of €79.39m and net profit of €73.87m

(EUR)	June 2026	YoY
Revenue	79.39m	-
Gross profit	44.25m	-
Net profit	73.87m	-
EBITDA	24.86m	-

Fundamentals

Metric	Value
Market capitalization	€2.63bn
Number of shares	55.34m
52-week high/low	€48.43 - €35.99
Dividend yield	2.54%
Dividends TTM	€1.10
Beta	0.17
P/E ratio	12.46
PEG ratio	-1.56
P/B ratio	0.60
P/S ratio	13.07

Company profile

Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company operates through three segments: Healthcare, Investments, and Others. The Healthcare segment principally manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brand. Its Investments segment invests primarily in quoted securities. In addition, the company owns and leases various investment properties that have lettable area of 45,324 square meters of commercial and industrial space in Singapore and Malaysia. Further, the company provides family and tourist oriented leisure alternatives principally in the form of oceanariums. Haw Par Corporation Limited leases land, building, and office space, as well as offers management support services. The company was incorporated in 1969 and is based in Singapore.